Idenix Pharmaceuticals Stock Price, News & Analysis (NASDAQ:IDIX)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Idenix Pharmaceuticals (NASDAQ:IDIX)

Idenix Pharmaceuticals logoIdenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. As of December 31, 2012, the Company's primary research and development focused on the treatment of patients with hepatitis C virus (HCV). In June 2012, the Company completed a three-day proof-of-concept study designed to evaluate 64 treatment-naive HCV genotype 1, 2, 3 or 4-infected patients. In July 2012, the FDA granted Fast Track designation for IDX719. The Company, as of December 31, 2012, was developing nucleotide polymerase inhibitors and NS 5A inhibitors to inhibits HCV replication, which include nucleoside/nucleotide polymerase inhibitors and NS5A Inhibitors. On January 25, 2013, the Company entered into a non-exclusive collaboration agreement with Janssen Pharmaceuticals, Inc for the clinical evaluation of all oral DAA HCV combination therapies.

Receive IDIX News and Ratings via Email

Sign-up to receive the latest news and ratings for IDIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryBiotechnology
SectorHealthcare
SymbolNASDAQ:IDIX
CUSIP45166R20
Phone+1-617-9959800

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Idenix Pharmaceuticals (NASDAQ:IDIX) Frequently Asked Questions

What is Idenix Pharmaceuticals' stock symbol?

Idenix Pharmaceuticals trades on the NASDAQ under the ticker symbol "IDIX."

Who are some of Idenix Pharmaceuticals' key competitors?

How do I buy Idenix Pharmaceuticals stock?

Shares of Idenix Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Idenix Pharmaceuticals?

Idenix Pharmaceuticals' mailing address is 320 Bent St, CAMBRIDGE, MA 02141-2025, United States. The biopharmaceutical company can be reached via phone at +1-617-9959800.


MarketBeat Community Rating for Idenix Pharmaceuticals (IDIX)

Community Ranking:  1.3 out of 5 (star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  171 (Vote Underperform)
Total Votes:  234
MarketBeat's community ratings are surveys of what our community members think about Idenix Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Idenix Pharmaceuticals (NASDAQ:IDIX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Idenix Pharmaceuticals (NASDAQ:IDIX) Earnings History and Estimates Chart

Earnings by Quarter for Idenix Pharmaceuticals (NASDAQ:IDIX)

Idenix Pharmaceuticals (NASDAQ IDIX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/31/2014Q214($0.22)($0.43)($26.07) millionViewN/AView Earnings Details
5/1/2014Q114($0.19)($0.24)$0.22 million($3.01) millionViewN/AView Earnings Details
2/27/2014Q413($0.22)($0.21)$0.15 million$0.50 millionViewN/AView Earnings Details
2/25/2013Q412($0.17)($0.17)$0.74 million$0.33 millionViewN/AView Earnings Details
11/1/2012Q312($0.17)$0.03$2.60 million$32.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Idenix Pharmaceuticals (NASDAQ:IDIX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Idenix Pharmaceuticals (NASDAQ:IDIX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Idenix Pharmaceuticals (NASDAQ IDIX) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Idenix Pharmaceuticals (NASDAQ:IDIX)

Idenix Pharmaceuticals (NASDAQ IDIX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/31/2014Baupost Group Llc/Mamajor shareholderBuy16,420,241$6.50$106,731,566.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Idenix Pharmaceuticals (NASDAQ IDIX) News Headlines

Source:
DateHeadline
Belgian scientists claim Delaware wrongly seized, sold stockBelgian scientists claim Delaware wrongly seized, sold stock
finance.yahoo.com - October 13 at 7:33 PM
Head-To-Head Analysis: Idenix Pharmaceuticals (IDIX) versus Grifols, (GRFS)Head-To-Head Analysis: Idenix Pharmaceuticals (IDIX) versus Grifols, (GRFS)
www.americanbankingnews.com - September 7 at 2:28 AM
Heres where Mercks new Cambridge research facility will be locatedHere's where Merck's new Cambridge research facility will be located
www.bizjournals.com - July 13 at 4:30 PM
3 Important Questions We Want Answered When Merck Reports Its Q2 Results3 Important Questions We Want Answered When Merck Reports Its Q2 Results
www.fool.com - July 27 at 9:02 AM
Activists want imminent retirement of Ariad CEOActivists want 'imminent retirement' of Ariad CEO
www.cnbc.com - February 20 at 11:24 AM

SEC Filings

Idenix Pharmaceuticals (NASDAQ:IDIX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Idenix Pharmaceuticals (NASDAQ:IDIX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Idenix Pharmaceuticals (NASDAQ IDIX) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.